Insider · CIK 0001423084
Thomas J. Schall
director
Files at IMRX (Immuneering Corp). First filing Jun 18, 2025, latest Jun 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$124k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Immuneering Corp | $35k 9,500 shares | +22% | - | |
| 49Moderate | Immuneering Corp | $89k 40,485 shares | +1396% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +9,500 | $3.66 | $35k | 52,885 | Jun 30, 2025 |
| Jun 17, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +40,485 | $2.21 | $89k | 43,385 | Jun 18, 2025 |
| Jun 13, 2025 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +33,350 | $0.00 | $0 | 33,350 | Jun 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.